A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.
about
Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabineEfficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@en
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@nl
type
label
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@en
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@nl
prefLabel
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@en
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@nl
P2093
P2860
P356
P1433
P1476
A Multicenter Phase II Trial o ...... resectable Gallbladder Cancer.
@en
P2093
Ji Kon Ryu
Ji Won Yoo
Jin-Hyeok Hwang
Joo Kyung Park
Jung Gyun Seo
Ki Young Yang
Sang Myung Woo
Woo Jin Lee
Yong Bum Yoon
Yong-Tae Kim
P2860
P304
P356
10.5009/GNL.2013.7.5.594
P577
2013-06-11T00:00:00Z